Setogepram Uses, Dosage, Side Effects and more
Setogepram is under investigation in clinical trial NCT03184584 (Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome).
| Attribute | Details |
|---|---|
| Trade Name | Setogepram |
| Generic | Setogepram |
| Type | |
| Formula | C13H18O2 |
| Weight | Average: 206.285 Monoisotopic: 206.13067982 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Innovators Monograph
Search Medicines
